chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt reported for vaccination on 2/22. Reported an LMP of 2/11. That report was actually vaginal bleeding. Pt discovered to be pregnant approximately 7 weeks on 2/24. Pregnancy outcome unknown.
Body Ache all over for 36 hours Fever of 102 for 24 hours Vomiting 6-8 hours sore throat  still present headache still present trouble swallowing  for 24 hours Dizziness for 12 - 14 hours
Rash; This is a spontaneous report from a non-contactable other healthcare professional. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not reported), via an unspecified route of administration on Feb2021 as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was unknown if patient had covid prior to vaccination. It was unknown if other vaccines were given in four weeks prior to vaccination. On an unspecified date on Feb2021, the patient experienced rash that occurred a few days after receiving the vaccine which resulted in emergency room visit. The patient took steroid cream as treatment for the event. It was unknown if patient tested for covid post vaccination. Outcome rash was unknown.    No follow-up attempts are possible. No further information is expected.
This is a 75-year-old male presents here today wanting discharged from his recent admission.  Has a recent history of #1 acute respiratory failure requiring 2 L oxygen per NC #2 COVID-19 treated with IV Remdesivir and po decadron, 3 questionable bacterial pneumonia #4 generalized weakness.   Patient is now on room oxygen.  Is requesting to go home.  He was just seen by physical therapy and states that he walked over 25 feet.  Social services also involved in case as there was discussion of potential ECF.  Patient is not interested in this and is wanting to go home.   Patient is currently alert and oriented.  Lungs are clear to auscultation cardio regular rate and rhythm.  Abdomen soft nontender.  Musculoskeletal legs with no edema no appreciated calf pain or
Moderna covid 19 vaccine EUA Low grade fever Aches Fatigue  Muscle pain Injection site: pain, tenderness, hardness
Immediately after receiving the shot, I experienced quite a bit of pain in my left arm.  After 5 minutes of receiving vaccination, I started to experience shortness of breath followed by rapid heart rate (which was confirmed by the nurse,) and lightheadedness.  I also found that I was shaking if I held my hand out in front of me.  After about 20 minutes after the shot, the shortness of breath, rapid heart rate and shaking subsided although I was still lightheaded.  I waited another 15 minutes until I only experienced mild lightheadedness and left.  The next day, my arm was still very sore (which lasted for 3 days) although I felt fine, however, experienced moderate fatigue and general achiness and just rested.  I experienced this also for 3 days with it lessening each day.  By the 4th day, my arm was only slightly sore and didn't feel much fatigue.
Day 2-3-severe pain in upper left arm Day 5-11 painful ache in left hand and wrist, itching "inside" upper left arm at injection site Day 12- current - itching on skin outside injection site Day 14-current - large inflamed/red/itchy area over upper left arm surrounding injection site.
Plugged/whooshing/ringing/popping ears; Pressure in head; Hands and feet get cold; Inability to concentrate; Foggy brain; Constant sinus drainage; Occasional sneezing; Dehydration; Dizziness; My hands and feet get cold they hurt; Vivid dreams; Popping ears; During meetings I find myself starting sentences but I cant finish them,; Insomnia; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 41-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On an unknown date, the patient experienced plugged/whooshing/ringing/popping ears, pressure in head, dizziness, especially when looked up after looking down at phone, hands and feet got so cold they hurt. The patient could put frozen feet by space heater and they did not warm up, they just hurt more, inability to concentrate and foggy brain. During meetings, the patient found herself starting sentences but she could not finish them, it was like she stopped and waited for her friends/family/co-workers to finish her thoughts. Other symptoms that did not bother her as much. Constant sinus drainage, occasional sneezing, dehydration, insomnia, vivid dreams and dizziness. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of reported events. The clinical outcome of the event plugged/whooshing/ringing/popping ears, pressure in head, dizziness, especially when looked up after looking down at phone, hands and feet got so cold they hurt, inability to concentrate and foggy brain, constant sinus drainage, occasional sneezing, dehydration, insomnia, vivid dreams and dizziness were not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient received her 2nd Hep B shot. When leaving building she told front desk that she felt flushed and tongue was thick. We admin EPIPEN and called 911. Also informed pt. sister in law.
Very severe local reaction swelling, redness, itching and warmth one day after given shot.
Eye pain and redness in left eye Unexplained dental pain, left side Pressure  around ears face and head,  left side Muscle pain in left leg and fingers
FEVER; CHILLS; HEADACHE; NAUSEA; SWEATING; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported,) dose was not reported, administered on 24-MAR-2021 11:30 for prophylactic vaccination. The batch number was not reported and has been requested.  No concomitant medications were reported.  On MAR-2021, the subject experienced sweating. On MAR-2021, the subject experienced nausea. On 24-MAR-2021 15:00, the subject experienced chills. On 24-MAR-2021 15:00, the subject experienced headache. On 25-MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101.7 F, 102.7 F. Treatment medications (dates unspecified) included: paracetamol, and acetylsalicylic acid/caffeine/paracetamol/salicylamide. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and headache on MAR-2021, and nausea, and had not recovered from fever, and sweating. This report was non-serious.
This retrospective pregnancy case was reported by a consumer (also the subject) and described the occurrence of premature birth in a 35-year-old female subject who was vaccinated with TWINRIX (GlaxoSmithKline) during pregnancy. A physician or other health care professional has not verified this report. Concurrent medical conditions included toxemia. On 7 December 2011 the subject received a dose of TWINRIX (details unknown) and experienced vaccine exposure during the third trimester of her pregnancy. Date of last menstrual period and estimated date of delivery were not provided. On 24 December 2011. 17 days after vaccination with TWINRIX, the subject delivered a live female at 36 weeks gestation [premature birth]. Delivery method, infant weight and APGAR scores were not reported. At the time of the report, the consumer reported that the infant was "doing well". The consumer attributed the premature birth to her toxemia, not to receiving TWINRIX.
sinus tachycardia, heart rate on rest would not go under 100bpm, chills, aches, tachycardia spiking upon standing up to 170bpm, dizziness, lightheaded, tachycardia lasting 48 hours
patient said she felt sharp pain in her back, was having trouble breathing, throat felt funny, face was red
This spontaneous report was received from a registered nurse and refers to a 4 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 18-JUL-2017, the patient was vaccinated with an improperly stored PROQUAD at a dose of 0.5 (units not specified), lot # N012491 with expiry date 17-OCT-2018 (dose number, route and anatomical location not reported) for prophylaxis. Concomitant therapies included a properly stored sterile diluent (manufacturer unknown). The administered dose of vaccine was stored in the temperature between 6 degrees Fahrenheit and 14 degrees Fahrenheit for 20 hours and in the temperature between 15 degrees Fahrenheit and 46 degrees Fahrenheit for 6 hours. There were no previous temperature excursions. Data logger was involved. No adverse effects were reported. No additional information was provided. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1707USA006208:
Pain in her head that went down to her ear; sinus pain; Almost fell out of chair when she tried to stand up; Legs felt like they were going to give out; Same thing happened the next day when she got out of bed in the morning; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (Pain in her head that went down to her ear), SINUS PAIN (sinus pain), FALL (Almost fell out of chair when she tried to stand up), FATIGUE (Legs felt like they were going to give out) and FEELING ABNORMAL (Same thing happened the next day when she got out of bed in the morning) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 10-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced EAR PAIN (Pain in her head that went down to her ear), SINUS PAIN (sinus pain), FALL (Almost fell out of chair when she tried to stand up), FATIGUE (Legs felt like they were going to give out) and FEELING ABNORMAL (Same thing happened the next day when she got out of bed in the morning). At the time of the report, EAR PAIN (Pain in her head that went down to her ear), FALL (Almost fell out of chair when she tried to stand up), FATIGUE (Legs felt like they were going to give out) and FEELING ABNORMAL (Same thing happened the next day when she got out of bed in the morning) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was reported. Concomitant product use was not provided by the reporter.
Pt c/o being dizzy, warm and sweaty, c/o nausea.  No issues reported after first vaccine
Information regarding PREVNAR 13 was received from a healthcare professional regarding an unknown number of patients who experienced administration of vaccine stored at 29 degrees C. The patients received a dose in 2010. The patients experienced administration of vaccine stored at 29 degrees C in 2010. No adverse events were reported. No additional information was available at the time of this report.
Client c/o lightheadedness immediately after receiving vaccine.  Client seen and assessed by EMS.  Vitals are as followed:  B/P 112/66, HR 66,  Client denies any other symptoms and states that she no longer felt symptoms after 15 minutes.  EMS cleared pt. to go home.
Body Aches Nausea Lymph's node in my left armpit was a size of a gulf ball
This spontaneous report was received from a medical assistant (also reported as nurse) and refers to an unspecified number of patients of unknown demographics. No information regarding patients' pertinent medical history, concomitant medications and drug reactions or allergies was provided. On unknown dates, patients were vaccinated with M-M-R II, subcutaneously (strength, dose, route of administration, anatomical location, lot# and expiration date were not provided) for prophylaxis. The medical assistant reported that the office ran out of the sterile diluent (manufacturer unknown) and used a sterile water (manufacturer unknown) to reconstitute the M-M-R II vaccine, on unknown dates. No adverse event was reported. Product quality complaint (PQC) was not involved. The outcome of the reported event was unknown. This is one of four reports from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1704USA015066: US-009507513-1704USA015064: US-009507513-1704USA015065:
Patient was given her first Pfizer COVID19 vaccine on 8/27. She became ill and tested positive for SARS-CoV-2 on 9/15/21. Was seen in ED 9/16/21 for shortness of breath, chills, body aches, sent home and recovered. She then received her second dose of the Pfizer vaccine on 10/27.    10/28, she has felt generally unwell, reports headache, soreness at the site of her vaccination injection, lightheadedness, shortness of breath, and fever (101.9F checked just prior to calling). She states that she has a history of asthma and takes albuterol PRN. Today, she has been taking it every 4 hours, with some initial help but she has noted that she begins to feel short of breath again sooner and sooner after last inhaler treatment. She feels a tightness in her chest, feels like her heart is "working harder than normal," and endorses orthopnea with increased chest tightness, SOB, and heart pounding when she is lying flat. While she does not have significant mid-sentence dyspnea listening to her on the phone, she states that she is having to breath very deeply while talking and feels like she can't catch her breath.  Patient seen in ED, discharged with supportive care, symptoms suspected due to COVID vaccination.
Patient received her vaccination and by that evening her injection side was slightly raised and itchy.  She used benadryl spray to try to alleviate the itching.  The redness spread down her arm and when she was seeing her heart doctor they recommended getting seen by her primary doctor and letting the pharmacy know of the reaction.  Her primary doctor didn't have any availability to see her so on 1/3/21 she went to the urgent care center.  They prescribed her Duricef 500mg.  They diagnosed her with cellulitis.  Her first dose was at 1pm on 1/4/22.  So far she hasn't not experienced any fever.
Guillain Barre; coma for almost two years; Initial information was received on 18-Nov-2021 regarding an unsolicited valid serious case from a Social Media via a consumer/non-health care professional.  This case involves a female patient (unknown age) who had Guillain Barre (Guillain-Barre syndrome) and coma for almost two years (coma) after receiving INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor.  The patient's past medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date (in 1992/1993), the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed serious Guillain Barre (Guillain-Barre syndrome) and coma for almost two years (coma) (unknown latency) following the administration of INFLUENZA VACCINE.   These events were assessed as medically significant.  The patient had to learn how to walk, talk and remember who was her family.   It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment for the events.  On an unknown date, after almost 2 years the patient was recovered from coma.  At time of reporting, outcome of the Guillain-Barre syndrome was unknown.  The reporter assessed the Guillain-Barre syndrome as related with suspect and did not report the causality of coma with suspect.  Information on batch number was requested for this case.; Sender's Comments: This case concerns a female patient (unknown age) who had Guillain-Barre syndrome and coma after vaccination with INFLUENZA VACCINE produced by unknown manufacturer. The time to onset is unknown. Additional information regarding patient's medical history, condition at the time of vaccination and laboratory data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.
Diffuse hives started ~ 12 hours post vaccine, progressively worsened to involve entire body, and required solumedrol & antihistamines at an Urgent Care visit
Confluent erythematous flushing of face, palms and soles with associated itching to the same areas and ear canals.  Symptoms started about 30 minutes after injection.
This spontaneous report as received from a medical assistant refers to 4 patients of unknown age and gender. No information regarding the patient's current conditions and medical history was provided. On unspecified dates, the patients were vaccinated with improperly stored, ROTATEQ oral lot # K001198 and expiry date of 25-OCT-2015 (unknown dose). Concomitant medications were not reported. No adverse effects were reported. The outcome of the event was unknown. Additional information has been requested.
No adverse effects; one dose of improperly stored vaccine, Gardasil 9, has been administered to one patient; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 14-AUG-2019, the patient was vaccinated with improperly stored hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, (lot # R032766 has been verified to be a valid lot number and expiration date reported as 14-AUG-2019 but upon internal validation established as 31-AUG-2021) (dose and route of administration were not reported) for prophylaxis. The temperature was 29.3 F (units not reported) for 7 hours and 57 minutes. There was no previous temperature excursion. Digital data logger was involved. No adverse effects were reported.
HE PRESENTED TO NURSE FOR COVID VACCINE WITHOUT VACCINE CARD AND DID NOT VOICE THAT HE HAD RECEIVED PRIOR COVID VACCINES.  HE COMPLETED CONSENT FORM FOR A 1ST DOSE PFIZER VACCINE AND HE WAS ADMINISTERED PFIZER FOR WHAT WAS THOUGHT TO BE HIS FIRST DOSE AND WAS NOT UNTIL I WAS ENTERING INTO DATABASE TODAY THAT NOTED HE HAD 1ST DOSE ON 01/15/2022 AND 2ND DOSE ON 02/05/2022 AT  PHARMACY.   I MADE TELEPHONE CONTACT WITH HIM TO CONFIRM THAT ADDRESS  AND TELEPHONE NUMBER IN DATABASE AND HE VOICED WAS GOOD BUT WHA T IS ON HIS CONSENT IS CORRECT PHYSICAL ADDRESS AND HIS TELEPHONE NUMBER. I DID INQUIRE IF HE HAD RECEIVED ANY COVID VACCINES PRIOR AND HE VOICED HE HAD GOTTEN "2 OTHER" COVID VACCINES AT PHARMACY.  HE VOICED THAT HE DID NOT TELL THE NURSE.  HE VOICED THAT HE HAS NOT HAD ANY ADVERSE REACTIONS OF ANY KIND.   I DID INFORM HIM THAT AS HAD COMPLETED HIS PRIMARY SERIES THAT SHOULD HAVE RECEIVED THE BIVALENT PFIZER BOOSTER ON 11/21/2022 BUT AS NURSE WAS NOT AWARE HE HAD RECEIVED PRIOR VACCINE AND THAT HE HAD COMPLETED THE CONSENT FORM THAT WAS WOULD BE  HIS FIRST DOSE HE WOULD BE ELIGIABLE FOR THE BIVALENT PFIZER BOOSTER 2 MONTHS FROM NOW. AND EXPLAINED DIFFERENCE IN VACCINES.  I DID ADVISE NEEDS TO GET UPDATED CARD WITH ALL OF VACCINES AND TAKE WITH HIM IF/WHEN GETS BOOSTER DOSE.  HE ACKNOWLEDGED AND HAVE ALSO NOTIFIED HEALTH MANAGER AT FACIITY WHERE HE RECEIVED THE VACCINE.
24 hours after receiving the vaccine, patient discovered a rash approximately 1/2 inch in width extending from the left corner of their mouth to about halfway down their neck (approximately 5 inches in length). The rash was washed with cool water and soap, and monitored.
pt was in the hospital and was  tested for covid pre-surgical testing and was positive. pt is asymtomatic
Feeling pretty awful; This case was reported by a consumer via interactive digital media and described the occurrence of feels awful in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 19th November 2021, the patient received the 2nd dose of Shingles vaccine. On 20th November 2021, 1 days after receiving Shingles vaccine, the patient experienced feels awful. On 21st November 2021, the outcome of the feels awful was recovered/resolved.   It was unknown if the reporter considered the feels awful to be related to Shingles vaccine.  Additional details were provided are as follows: The case was reported by patient for himself/herself. The age at vaccination was not reported. The patient had a shot of Shingles vaccine on Friday and felt pretty awful on Saturday. On the day of reporting, the patient was fine. The patient stated getting the shot was so worth it because the uncomfortable side effects of the shot were nothing like the devastating effects of having shingles. The follow-up could not be possible as no contact details were available.
Diarrhea x 10 days, 5-6 times a day. MR received revealing that after 2 month vax. infant began having 5-6 mucusy stools/day. This continued for 10 days but began to taper in number toward the end. Day 12 s/p vax. mother reports still having smelly mucusy stools less frequently. No vomiting, no fever, appetite good.  No other F/u records. Office RN reports speaking with mom ~3 weeks s/p vax. and stools are 1/day and normal.
Patient was observed post Covid-19 immunization for 30 minutes based on pre-vaccination screening and reported to RN that she was feeling lightheaded and dizzy after about 20 minutes of observation. States she is feeling slightly anxious. BP 160/96 pulse 108 sat 98%. Patient is not reporting any other symptoms.  Patient reports a History of HTN and anxiety States she does not normally feel lightheaded/dizzy. States this BP is elevated for her. Patient given water and crackers, with slight relief of dizziness. EMS called and at pt side for evaluation. At 1212p, Bp 173/91, hr 94, sat 97% given cracker and water, which patient stated made her feel slightly better. EMS evaluating patient Emotional support provided. At 1220, BP 182/98, pulse down to 85, with sats at 95%. Patient feeling better. EMS transported patient to a quite space and continued to monitor. Patient speaking with husband as well. At 1242, EMS released stating patient feeling better and BP down to 160/90. Patient encouraged to discuss with PCP events.  She was provided with Vaccine Information Sheet and instruction to access the V-Safe system. Patient was observed post Covid-19 immunization for 30 minutes based on pre-vaccination screening and reported to RN that she was feeling lightheaded and dizzy after about 20 minutes of observation. States she is feeling slightly anxious. BP 160/96 pulse 108 sat 98%. Patient is not reporting any other symptoms.  Patient reports a History of HTN and anxiety States she does not normally feel lightheaded/dizzy. States this BP is elevated for her. Patient given water and crackers, with slight relief of dizziness. EMS called and at pt side for evaluation. At 1212p, Bp 173/91, hr 94, sat 97% given cracker and water, which patient stated made her feel slightly better. EMS evaluating patient Emotional support provided. At 1220, BP 182/98, pulse down to 85, with sats at 95%. Patient feeling better. EMS transported patient to a quite space and continued to monitor. Patient speaking with husband as well. At 1242, EMS released stating patient feeling better and BP down to 160/90. Patient encouraged to discuss with PCP events.